RP
REGENERON PHARMACEUTICALS
REGN· Health Care· BiotechnologyS&P 500
Close · 16/09/2026
774.61
1D
+0.06%52-week range
541 – 859.34
Volume
3,82,900.00
Price history
REGN
17/08/2026 to 16/09/2026
O 775.82 H 779.98 L 771.80
1W-4.09%
1M-3.89%
3M+26.01%
6M+2.05%
1Y+35.28%
3Y-7.07%
5Y+15.75%
MAX+33.31%
Fundamentals
as of 16/09/2026- Market cap
- $72.78B
- Shares out
- 93.96M
- P/E (trailing)
- 16.81
- P/E (forward)
- 12.89
- EPS (trailing)
- 46.07
- Dividend yield
- 0.48%
- Beta
- 0.19
- Profit margin
- 27.86%
- P/B
- 2.30
- Return on equity
- 13.65%
SEC financial statements
63 quarterly and 18 annual periods through 30/06/2026.
Details
- Ticker
- REGN
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 16/09/2026.
Tracked by Congress
12 filers · 2 on watchlist · 12 buys · 22 sells · ?: 1 · D: 25 · R: 8
- 27/03/2026Alan ArmstrongBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 15/05/2026Gilbert CisnerosSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 12/02/2026Julia LetlowBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 18/11/2025Gilbert CisnerosBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 15/05/2025Rob BresnahanBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 10/04/2025Byron DonaldsSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 10/04/2025Byron DonaldsSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 01/04/2025Julie JohnsonSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000